More Support for Allergen-Exposure Strategy

A second study finds evidence that feeding children peanuts could help prevent them from developing allergies to the legume later in life.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, USDAIn February 2015, an international team of researchers published the results of a study, termed the Learning Early about Peanut Allergy (LEAP) trial, that suggested it was possible to lower the risk of peanut allergies in infants at high risk by exposing the babies to the legume, challenging years of advice to parents to avoid giving their babies peanuts. Now, a follow-up study of these children, published Friday (March 4) in the New England Journal of Medicine (NEJM), supports this exposure-based tactic, finding that, even after avoiding peanuts for a year, kids who had regularly consumed peanut-containing foods during the previous study were far less likely to be allergic. While more than 18 percent of children who had avoided peanut exposure during both trials developed peanut allergies, fewer than 5 percent of exposed children did.

“Giving peanuts very early on actually protected them from developing a peanut allergy,” Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told NPR’s The Salt. “It’s a very important proof of concept.”

“This new study is great because . . . it looks like the benefit [of early exposure] is essentially permanent,” Scott Sicherer, a pediatric immunologist and allergy specialist at Mount Sinai Hospital in New York City, told The Salt.

A second study published last week in (March 4) in the NEJM hints at the possibility that exposure at a young age to other allergenic foods such as eggs, wheat, and milk could have a similar benefit, though the results were not as conclusive. In this Enquiring about Tolerance (EAT) ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies